Burnet Institute

Medications

New insights into medicines for preeclampsia

Burnet Institute researchers have led the development of the first global strategic guidelines—called target product profiles (TPPs)—for medicines to prevent and treat preeclampsia, a hypertensive disorder in pregnancy ...

Diseases, Conditions, Syndromes

Reducing the impacts of chlamydia in Australia

We need to do more to prevent and manage chlamydia in Australia, argues a new Perspective article led by Burnet Institute and published in the Medical Journal of Australia on November 7.

page 2 from 5